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Abstract 
Background and purpose 
Negative psychological outcomes occur frequently after stroke, however there is 
uncertainty regarding the occurrence of anxiety disorders and anxiety symptoms after 
stroke.  A systematic review of observational studies was conducted that assessed the 
frequency of anxiety in stroke patients using a diagnostic or screening tool.   
Summary of review 
Databases were searched up to March 2011.  A random effects model was used 
to summarize the pooled estimate.  Statistical heterogeneity was assessed using the I2 
statistic.  Forty-four published studies comprising 5,760 stroke patients were included.  
The overall pooled estimate of anxiety disorders assessed by clinical interview was 18% 
(95%CI 8% - 29%, I2 = 97%), and was 25% (95% CI 21%-28%, I2 = 90%) for anxiety 
assessed by rating scale.  The Hospital Anxiety and Depression Scale- Anxiety 
subscale (HADS-A) probable and possible cut-off scores were the most widely used 
assessment criteria.  The combined rate of anxiety by time after stroke was: 20% (95% 
CI 13%-27%, I2 = 96%) within one month of stroke; 23% (95% CI 19%-27%, I2 = 84%) 1 
to 5 months after stroke; and 24% (95% CI 19%-29%, I2 = 89%) 6 months or more after 
stroke.   
Conclusion 
Anxiety after stroke occurs frequently although methodological limitations in the 
primary studies may limit generalizability.  Given the association between prevalence 
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rates and the HADS-A cut-off used in studies, reported rates could in fact under-
represent the extent of the problem.  Additionally risk factors for anxiety, its impact on 
patient outcomes, and effects in tangent with depression remain unclear. 
 
 
Introduction 
Globally, anxiety disorders are the most common mental health problem (1).  In 
some instances anxiety is functionally appropriate and even advantageous when it 
prompts protective health behavior, and a certain level would be considered a normal 
reaction to experiencing a life threatening event such as stroke.  However, anxiety 
disorders and substantially elevated levels of anxiety symptoms are associated with 
reduced quality of life (2), lead to increased healthcare utilization, and risk of disabling 
health conditions (3, 4), and may even augment risk of death (5). 
The Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)(6) classifies 
anxiety disorders as a collection of individual syndromes that include generalized 
anxiety disorder (GAD), panic disorder (with or without agoraphobia), agoraphobia (with 
or without panic), specific phobia, social phobia, obsessive compulsive disorder (OCD), 
posttraumatic stress disorder (PTSD), acute stress disorder, anxiety disorder due to a 
general medical condition, substance induced anxiety disorder, and anxiety disorder not 
otherwise specified.  Each disorder has certain distinct features yet they all share similar 
hallmark characteristics of excessive and irrational fear, feeling apprehensive and tense, 
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and difficulty and distress in managing daily tasks.  Certain physiological symptoms 
such as palpitations, dizziness or trembling may also be present. 
Anxiety has received substantially less attention relative to other psychological 
problems that occur post-stroke (7-9).  Several reasons attribute to its neglect.  Early 
population-based prevalence studies found that the frequency of anxiety disorders after 
stoke was low (10).  This would seem to be in keeping with epidemiologic studies in the 
general adult population that suggest that anxiety disorders are uncommon among older 
adults, and approximately three quarters of stroke patients are over 65 years of age (11).  
However, one of the diagnostic challenges for assessing mood in stroke patients is that 
some symptoms of disorder, such as sleep disturbance or fatigue, are common 
consequences of stroke itself.  This may have the effect of falsely reducing reported 
rates of mood disorder when using DSM criteria (12).  
As a result of these diagnostic challenges the study of anxiety symptoms 
assessed by rating scales and not meeting full DSM criteria has proved extremely 
relevant.  Studies have shown that people with sub-threshold symptoms and diagnosed 
anxiety disorders are similarly affected by the anxiety (12).  Many stroke patients report 
substantial fears (possibly indicative of phobic disorders) about recurrent stroke, falling, 
or returning to work (13-15) that would be unlikely to constitute diagnosis of an anxiety 
or related mental health disorder, yet appear to impact significantly on daily living. 
Additionally co-morbidity of anxiety and depression is well documented (16).  
Traditional diagnostic and treatment approaches have used a hierarchical approach 
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with depressive symptoms taking precedence. Further, some argue that certain forms of 
anxiety should be conceptualized as a residual or severity marker of depression (17).  
However, factor analysis has found that anxiety and depression appear to be distinct 
(16, 18) (19), and a differential response to treatment between the two conditions has 
been observed (20). The extent to which anxiety is a problem after stroke is uncertain.  
The aim of this review was to estimate the frequency of anxiety disorders after stroke.  
We were also interested in the frequency of anxiety ‘caseness’ as determined by a 
score on anxiety rating scales.  A robust estimate of post-stroke anxiety prevalence is 
needed to assess its potential impact and highlight treatment needs._ENREF_18 
METHODS 
Inclusion / exclusion criteria 
The review included studies in populations or groups of patients who had a 
clinical diagnosis of ischemic or hemorrhagic stroke or transient ischemic attack (TIA), 
and were diagnosed with an anxiety disorder, or assessed for anxiety symptoms on a 
rating scale such as the Hospital Anxiety and Depression Scale (HADS).  Non-English 
language papers that were potentially eligible based on their title or abstract were 
translated.  Studies were excluded if they: (1)  were intervention studies; (2) were 
limited to patients with subarachnoid hemorrhage or other select characteristic such as 
gender; (3) used non-specific measures of psychological distress but not designed to 
screen expressly for an anxiety; (4) involved retrospective recruitment or reporting of 
mood; (5) used convenience sampling; (6) reported anxiety as a continuous outcome 
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and we were unable to obtain a categorical assessment from the author or; (7) 
measured anxiety by proxy. 
Study identification and data extraction 
Electronic searches in MEDLINE, EMBASE, PsycINFO, Allied and 
Complementary Medicine, CINAHL, and Proquest dissertation were conducted using 
the terms “stroke” or “cerebrovascular disorders” or “cerebrovascular accident” in 
combination with “anxiety disorders”, or “adjustment disorders”, or “neurotic disorders”, 
or “mental disorders”, or “worry”, or “fear”.  We combined the search terms with the 
“explode” feature and no language restrictions were put in place (see Appendix 1 for 
detailed search strategy).  One investigator (ACB) conducted the initial search from 
database inception to March, 2010 and updated it up to March, 2011.  Reference lists 
from included studies were checked, and study authors were contacted for additional 
data where necessary.   
One reviewer (ACB) screened and identified studies against the selection criteria.  
A second reviewer (PK) conducted a random check of approximately 10% of titles and 
abstracts to check reliability of initial screening.  Independent data extraction by two 
reviewers (ACB and PK) was performed for all eligible studies.   
Quality of evidence 
Information about study design, setting, and patient characteristics was extracted.  
Study quality was assessed using a modified version of the tool for systematic reviews 
of observational studies (QATSO)(21) and each study was evaluated based on the 
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method of recruitment into study, instrument used to measure anxiety, proportion of 
eligible patients who participated, proportion lost to follow-up (if applicable), and 
adequacy of descriptive details about the study populations.  At a minimum it was 
expected that age and sex would be reported. 
Data synthesis 
Studies were grouped into four categories based on method of case 
ascertainment.  Population-based studies which attempted to recruit all stroke survivors 
in a particular geographical area over a given period of time.  These are regarded as the 
least biased method to identify cases in cohort studies.  Hospital- and rehabilitation-
based studies that recruited in-patients,or those attending rehabilitation facilities.  Lastly 
community-based studies that recruited patients who were not in hospital or 
rehabilitation facilities and made no attempt to include all stroke cases in the geographic 
area (e.g. only patients from select general practices were included).  Studies were also 
stratified by three time periods: the “acute phase” (defined as less than one month post-
stroke), “mid-term phase” (one to five months post-stroke), and “long-term phase” (six or 
more months post-stroke).    
Several meta-analyses were conducted.  Studies using the DSM-III (80) were 
excluded from the pooled result as this classification system adheres to a strict 
hierarchical rule no longer used in practice, whereby anxiety is not diagnosed in the 
presence of depression.  For studies that used rating scales, we accepted whatever 
threshold score for ‘caseness’ that had been selected by the primary researchers.  In 
studies that measured anxiety over more than one time point, the earliest measurement 
Anxiety after stroke 
8 
 
 
from each study was used in the meta-analysis for calculating overall prevalence rates.  
This was considered to be the most robust estimate, with the most complete follow-up 
data.  Other meta-analyses stratified findings by source of study population (population; 
hospital, rehabilitation, or community) and time-period post-stroke and used the same 
inclusion criteria described above.  Data were summarized using the random effects 
model which takes into account heterogeneity within and between studies.  Chi-square 
was used to test for sub-group differences, and heterogeneity among the studies was 
assessed using the I2 statistic.  Heterogeneity is considered substantial if the I2 statistic 
is greater than 50%.(22)  Analysis was carried out using RevMan 5.1.   
RESULTS 
The search produced 21,432 references, of which 50 publications (from 41 
studies) met the inclusion criteria in March 2010.  Ten studies which could have 
potentially contributed to the review findings were excluded as authors were unavailable 
to provide necessary information. Reasons for exclusion were: reporting anxiety as a 
continuous outcome (23-26), using a rating scale that measured anxiety but not 
reporting anxiety findings (27-30), reporting only patients with co-morbid anxiety and 
depression (31), reporting only correlational data between anxiety and another variable 
(32), an unpublished thesis that was not accessible (33).  The total number of 
participants in these excluded studies is 931.  An updated search run in March 2011, 
found three additional studies, giving a total of 44 studies in this review. 
Study characteristics 
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Five studies were population-based and  included 1,054 stroke survivors from a 
base population of 1,199,782. (10, 34-39)  Three studies were limited to those with first 
ever stroke,(10, 35, 37) one excluded those with subarachnoid hemorrhage,(36)  and all 
excluded people with major cognitive impairment, dementia or communication 
difficulties.  Anxiety was assessed one month to five years post-stroke, and 60%-100% 
of eligible patients participated. The mean age of participants ranged from 66-71 years, 
with males representing 51%-64% of the sample (see Table 1).  All studies were based 
on assessments from patients enrolled in a local stroke registry system.   
There were 20 hospital (2, 40-58) and 14 rehabilitation based studies (59-73) 
which included 2,163 and 2,200 patients respectively.  Allhad variable inclusion criteria 
(see Table 1).  Additionally, there were five community-based studies (74-78) including 
343 patients (see Table 1).  One study accounted for 33% of the stroke participants (78).  
Among these three study types participation rates ranged from 31%-92%, and eight 
studies (43, 44, 46, 47, 57, 62, 76, 79) failed to provide information about the number of 
eligible stroke patients.  Mean age ranged from 51-76 years with males comprising 
45%-72% of the study population (see Table 1).  The 44 included studies were 
published between 1984 and 2010 and included two studies reported in non-English 
language papers (xx, xx).  
Measurement and assessment of anxiety 
Clinical diagnoses of anxiety disorders were made in eight studies in accordance 
with different versions of the DSM.  The DSM-III (80) was used in three studies (10, 39, 
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48), and three studies (34, 40, 72) used the DSM-III-R(81). The Oxfordshire Community 
Stroke Project (OCSP) used the DSM-III-R for its long-term follow-up so it is counted in 
the DSM-III, and DSM-III-R category (ref). Another three studies (45, 51, 53) used the 
DSM-IV (6).  Eight different standardized scales were used to identify anxiety symptoms 
(Table 2).  One study used a single question measure(69), and another used  a series 
of five researcher developed questions to identify anxiety (74).    
Anxiety Prevalence 
Overall prevalence of anxiety disorders was 18% (95%CI 8%-29%, [I2=97%, 
p<0.001]) (figure 1).  Although the Perth Community Stroke Study (PCSS) used the 
DSM-III it did not apply the hierarchical diagnostic rule, so it has been  included in the 
meta-analysis.  One study (72) with an unusually low prevalence estimate contributed 
all of the heterogeneity of the I2 statistic. The prevalence of anxiety disorders excluding 
this study is 20% (95%CI 18% - 23%, [I2=0%, p=0.65]).   Three studies,(34, 39, 51) 
measured different anxiety types and found that phobic disorders then GAD were the 
most common.  One study that looked exclusively at GAD differentiated between 
primary GAD and GAD due to stroke. (45)  It found that just over half of the anxiety 
cases received a primary diagnosis. 
The overall frequency of anxiety ‘caseness’ when assessed by rating scale was 
25% (95% CI 21%-28%, [I2=90%, p<0.001]) (see Figure 1).  The HADS-A was the most 
commonly used rating scale (see Table 2).  The majority of these studies used a HADS-
A cut off of 8/9 or 10/11 to define ‘possible’ or ‘probable’ anxiety.  Studies using lower 
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cut-off on the HADS-A reported higher prevalence rates relative to those using the 
‘probable’ threshold ([28%, 95%CI 21-35] vs [18%, 95%CI 13-23%], I2= 79%, p=0.03).  
Assessment of the funnel plot (see Figure 2) revealed more asymmetry amongst 
studies with lower cut-off scores relative to those using the ‘probable’ threshold, 
indicating possible publication bias in favour of studies with higher prevalence estimates.  
Post-hoc analysis found no significant difference between studies that only included 
first-ever stroke compared to those with recurrent stroke (21% vs. 25%, respectively). 
     
Time Course, Co-morbidity and Treatment 
 As the rates of anxiety reported by clinical interview and rating scales did not 
differ statistically, they were combined for the remaining stratified meta-analyses.   
There was a non-significant increase in the prevalence of anxiety over time (see Figure 
3).  Overall frequency was 20% (95% CI 13%-26%, [I2= 96%, p=0.0.001]) in the acute 
phase; 23% (95% CI 19%-27%, [I2= 84%, p=<0.001]) one to five months post-stroke; 
and 24% (95%CI 19%-29%, [I2=89%, p=<0.001]) six months or more post-stroke.  
Anxiety prevalence was significantly lower in the acute phase rehabilitation-based 
studies relative to the other stratified subgroups, 13% (95% CI 4%-21%, I2= 97%).  
Overall pooled population-based estimates (25%) did not yield significantly lower 
anxiety prevalence estimates than those from hospital-, rehabilitation-, or community-
based populations (25% vs. 21% vs. 22%, respectively).  
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Three studies examined the time course of anxiety within individual stroke 
patients.  The Collaborative Evaluation of Rehabilitation in Stroke across Europe study 
(63) found that 40% of patients with anxiety two months after stroke, remained anxious 
four months later, and 7-11% of patients not anxious at two months became so two to 
four months later.  The population-based Perth Community Stroke Study 
(39)_ENREF_26 found that 16% of patients with anxiety disorder at four months post-
stroke, remained anxious eight months later.  A similar trend was observed in a small 
study by Astrom (40), who reported that after three years post-stroke 62% of patients 
with early onset GAD had not recovered, however the small sample size from this last 
study mean results should be interpreted with caution.   
Three studies (39, 45, 71) reported pre-stroke mood disorders and found that 
approximately one third of patients with post-stroke anxiety had a history of pre-stroke 
mood or anxiety disorder.  Ten studies reported co-morbidity of anxiety and 
depression,(2, 39, 40, 42, 45, 51, 53, 59, 60, 70) and found that 17-80% of those with 
anxiety also had depression.  No study reported whether stroke patients received any 
form of treatment for their anxiety.  Additionally, two population-based studies with 
community-matched controls found no difference in anxiety prevalence rates between 
stroke and non-stroke patients (39) (10).  
Clinical Correlates 
Investigating anxiety was rarely a primary aim of the studies included in the 
review.  As such, factors that might be associated with anxiety were inconsistently 
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reported.  The variables correlated with anxiety and described in this section are those 
that were reported in five or more studies included in the review. There was a positive 
association between depression and anxiety in all six studies (45, 50, 53, 61, 67, 76) 
where it was assessed.  Additionally 4 of 5 studies (2, 47, 56, 67, 74) found a negative 
correlation with quality of life.  Findings were mixed for activities of daily living with 3 
studies (40, 42, 45) reporting a significant negative correlation and four studies (40, 41, 
51, 57) finding no association with anxiety.  No association was observed with age in six 
of eight studies (40, 42, 45, 46, 51, 56, 59, 61); gender in five of seven (40, 45, 46, 51, 
53, 59, 61); or lesion location in five of six studies (34, 40, 42, 45, 59, 65). It is likely that 
the probability of having anxiety after stroke is increased by having it before the stroke, 
but this relationship was not reported in enough studies to assess it convincingly.         
Quality of evidence  
Method of recruitment into studies was variable.  The majority used consecutive 
recruitment and prevalence did not differ from those studies that used a comprehensive 
registry.  However studies using random selection of participants tended to report higher 
rates.  There was also variability in prevalence estimates based on the rating scales 
used.  As many of them were used in only one study it is unclear whether this variability 
is due to the scale itself or some other underlying characteristic of the study population.  
The proportion of the eligible population was associated with prevalence.  It was lowest 
in studies whereby 60% or more of eligible individuals participated in the study (21%).  
Higher prevalence was observed in studies with less than 60% of eligible individuals 
included (25%), and was even higher for studies whereby the proportion participating 
Anxiety after stroke 
14 
 
 
was unclear (32%).  None of the studies with longitudinal follow-up lost more than 50% 
of their sample at the subsequent time-point and the majority of studies provided a 
sufficient level of detail to characterize the study population. (Table 1) 
DISCUSSION  
To our knowledge this is the first published systematic review of anxiety 
prevalence after stroke.  Anxiety disorders diagnosed by interview and anxiety 
symptoms assessed by rating scale occurred in approximately 20-25% of patients at 
any time after stroke.  Phobic disorders and GAD were the most common types, 
however this is based on findings from only three studies. The HADS was the most 
used rating scales.  Sensitivity for detecting anxiety disorders using the HADS-A in 
stroke patients using the ‘probable’ cut-off score ranges between 0.35 and 0.52 (82, 83), 
and is only marginally better when using the ‘possible case’ threshold.  As a result the 
overall prevalence of significant anxiety symptoms has likely been underestimated.  A 
recent validation study of the HADS-A in stroke patients found a score of 4 or 5 was the 
optimal cut-off when screening for anxiety (83).  At this level the suggested 
requirements for psychological screening tools in stroke to have a sensitivity of >0.8 and 
specificity of >0.6 (84) are best met.  Anxiety prevalence appears to increase somewhat 
over time however the increase is not statistically significant.  It is possible that the lack 
of significance could be due to the stratified time-periods chosen a priori, however post-
hoc analysis selecting different time-points also did not show a significant increase over 
time.  With the exception of rates being lower in rehabilitation studies during the acute 
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phase post stroke, no significant difference was observed based on setting from which 
participants were recruited (e.g. population vs hospital).  We hypothesize that the lower 
rate observed in the acute rehabilitation studies could be due to the structured 
supportiveenvironment, or the notion that patients deemed appropriate for rehabilitation 
may be less disabled and as such less likely to be anxious. Given that anxiety 
prevalence beyond the acute phase is the same amongst rehabilitation patients as in 
other groups of patients, it is perhaps indicative of a negative shift in these patients’ 
perceptions of their rehabilitation potential and chances of returning to their pre-stroke 
functional level.  The discrepancy in stroke sub-types, stroke severity, and variability of 
diagnostic tools and rating scales likely contribute to the high level of heterogeneity, and 
there is insufficient information to determine whether the anxiety reported was a 
consequence of stroke, as the majority of studies only made cross-sectional 
assessments and did not consider the presence of pre-stroke anxiety levels.  
Additionally, other factors that could impact the validity of prevalence estimates, such as 
medication use, the presence of cognitive or communication impairment, or previously 
having an anxiety disorder were not investigated. 
Despite having stratified our analyses by study population and timing there was 
significant heterogeneity in the pooled estimates which impacts on the generalizability 
and interpretation of findings.  Few studies differentiated between ‘first-ever anxiety’ and 
‘current anxiety’ making it impossible to determine whether the differences in estimates 
represent genuine discrepancies or were due to measurement error or methodological 
differences.  Second,  the variation in rating scale cut-points likely contributed to 
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heterogeneity of pooled estimates.  The review relied on studies being catalogued in 
major search databases and there was some evidence of small study effects such as 
publication bias.  Additionally some studies were not included in the review as their data 
was unavailable and the influence this would have on the overall findings is uncertain.  
With the exception of the HADS and the BAI, the other scales used in these studies 
have not been validated in stroke populations, so their sensitivity and specificity are 
unknown.  The HADS was most commonly used however it focuses on the psychic 
component of anxiety; as such anxiety-related physical symptoms not attributed to 
stroke are not taken into account.    
CONCLUSION 
 This review shows that while there has been a large number of studies 
investigating and reporting on the frequency of anxiety after stroke, there is scant 
information about timing of onset, risk factors and outcomes.  There also remains a lack 
of clarity about potential management strategies.  A recent systematic review of 
interventions used to treat anxiety after stroke found limited evidence for use of 
pharmaceutical drugs (85) however other forms of treatment may be more suitable. For 
example, guided self-help, applied relaxation and cognitive behavioral therapy have all 
been shown to be effective in the general adult population (86).  There is also a need to 
develop mood assessment tools appropriate for stroke patients with aphasia or severe 
communication problems, as these individuals are generally excluded from research.  
To date the one visual analogue mood scale found to be adequate in identifying 
depression post-stroke, has proved insufficient in the assessment of anxiety.  
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Most studies tend to examine the phenomena of anxiety and depression in 
isolation.  However the common use of mood scales such as the HADS could facilitate 
an evaluation  of the impact on patients of anxiety in addition to depression.  There may 
also be differential outcomes for those with anxiety only, depression only and co-
morbidity, however the design of most studies does not allow for any conclusion on this 
issue.  Additionally, given the variability in cut-off scores used in research studies, clear 
guidance on the appropriate point to screen for anxiety is needed, as this would reduce, 
at least marginally, the heterogeneity among future studies and provide more clarity to 
clinical decisions about treatment.  Recent large-scale surveys have reported 
dissatisfaction with the provision of psychological services after stroke  (87). The  high 
prevalence of anxiety in combination with a lack of available support and treatment 
likely contribute to this finding.  Given the pervasiveness of anxiety after stroke an 
understanding of its impact on the  patient and its economic burden, is warranted.   
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Table 1: Summary of included studies 
Study name or 
author, 
 year published 
Location 
Setting/ 
Design/  
Recruitment/ 
Year of study 
Inclusion (I)/ 
exclusion (E) 
Other Measures 
administered 
% Eligible 
participating 
Mean age 
(%male)/ 
 
N Criteria Time Post 
Stroke 
Percent with 
Anxiety (95% 
CI) 
Oxfordshire 
Community Stroke 
Project (OCSP) 
1991(10) 
UK 
Population/ 
Longitudinal 
cohort/  
All 1
st
 ever 
stroke entered 
in registry/ 
Nov 1981-Oct 
1986 
I: 1
st
 ever stroke 
(CT)  
E: recurrent 
stroke, TIA 
FAST, MMSE, BDI 93% 71 yrs 
45% 
89 DSM-III (GAD) 1m   1.1 (0-3) 
96% 119 6m  0.8 (0-3) 
97% 112 1y 0 
          
Oxfordshire 
Community Stroke 
Project (OCSP-II) 1990 
(34) 
UK 
   80% 62% male 60 DSM-III-R 
Anxiety (ALL) 
Agoraphobia 
GAD 
Simple phobia 
Panic disorder 
 
2-5y 
 
20(10-30) 
8.3 (1.3-15.3) 
5.0 (0-11) 
5.0 (0-11) 
2.0 (0-5) 
          
Perth Community 
Stroke Study (PCSS) 
1995(39)_ENREF_
26  
Australia 
Population 
based/ 
Longitudinal 
cohort/ 
Ideal case 
finding method/ 
1995-1996 
I: 1
st
 ever or 
recurrent stroke 
or TIA (WHO 
dfn) 
Clinical variables 60% 73 yrs (56%) 294 DSM-III* 
Anxiety (ALL) 
Agoraphobia 
GAD 
4m  
19 (14-23) 
16 (12-20) 
3 (1-5) 
          
South East London 
Stroke Study (SELSS) 
1997(35)   
UK 
Population/ 
Longitudinal 
cohort/ 
All strokes 
recorded in 
I: 1
st
 ever stroke 
in persons <75 
including those 
who did not 
survive initial 
BI, SF-36, FAI, NHP, 
mRS, MMSE, QoL 
70% 71 yrs median 
(54%) 
96 HADS-A≥ 8 5y 31(22-41) 
Anxiety after stroke 
24 
 
 
Study name or 
author, 
 year published 
Location 
Setting/ 
Design/  
Recruitment/ 
Year of study 
Inclusion (I)/ 
exclusion (E) 
Other Measures 
administered 
% Eligible 
participating 
Mean age 
(%male)/ 
 
N Criteria Time Post 
Stroke 
Percent with 
Anxiety (95% 
CI) 
register/ 
1989-1990 
event 
          
North East Melbourne 
Stroke Incidence 
Study (NEMSIS) 2004  
(37, 38)  
Australia 
*Anxiety prevalence 
data unpublished 
Population/ 
Ideal case 
finding method 
May 1996-Apr 
1999 
I: 1
st
 and 
recurring stroke 
(WHO dfn, CT or 
MRI) 
BI, LHS, NIHSS, 
clinical variables 
Unclear Unclear 475 IDA-A 
(score 9-15) 
3m 13 (10-16) 
498 1y 10 (7-13) 
201 2y 11 (6-15) 
424 5y 8.5 (6-11) 
          
Hachiman Stroke 
Registration System 
(HSRS) 1999(36) 
Japan 
Population/ 
Cohort/ 
All strokes 
entered in 
registry/ 
Jan-Dec 1987 
I: All strokes Researcher 
developed 
questionnaire 
covering range or 
clinical and social 
factors, Visual 
analog scale to 
measure stroke 
recovery 
66% 66 yrs (64%) 47 GHQ-60-≥3 out of 7 
on anx subscale 
2.5y 43 (29-57) 
          
Astrom, 1996 (40) 
Sweden 
Hospital, 
Longitudinal 
cohort, 
Consecutive  
Oct 1979-Jan 
1981 
I: Ischemic, 
hemorrhagic & 
TIA (CT) 
E: Congenital 
mental 
handicap 
 Hemisphere lesion, 
ADL, Living 
conditions, 
psychosocial 
function, prestroke 
psychiatric 
disorder, 
antidepressant 
usage 
72% 73 yrs (61%) 71 DSM-III-R(GAD) 2wk 28 (18-39) 
78% 70 3m 31 (21-42) 
83% 66 1y 24 (14-35) 
86% 57 2y 25 (13-36) 
86% 48 3y 19 (7.7-30) 
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Study name or 
author, 
 year published 
Location 
Setting/ 
Design/  
Recruitment/ 
Year of study 
Inclusion (I)/ 
exclusion (E) 
Other Measures 
administered 
% Eligible 
participating 
Mean age 
(%male)/ 
 
N Criteria Time Post 
Stroke 
Percent with 
Anxiety (95% 
CI) 
Donnellan, 2010(2) 
Ireland 
Hospital,  
Cross-sectional, 
Consecutive 
admissions,  
Not stated 
I: 1
st
 or 
recurrent stroke 
(WHO dfn, CT) 
& FAST ≥14, & 
AMT  ≥8  
E: TIA, SAH, 
traumatic 
intracranial 
haemorrhage, 
dementia, 
extreme critical 
illness  
Marital status, 
living 
arrangements, SES, 
ADL, NEADL, SSQOL 
53% Range 20-98 yrs 
(51%) 
107 HADS-A≥8 1m 33 (24-42) 
 107  1y 32 (23-41) 
          
Field, 2008(41) 
UK 
Hospital/ 
Cross-sectional/ 
Nurse 
approached all 
patients 
meeting 
inclusion 
criteria/  
Year not stated 
E: Cognitive 
impairment, 
aphasia, acute 
medical 
problems 
PTCI, PDS 
 
89%  72 yrs (53%) 81 HADS-A≥11 <1m 21 (12-30) 
          
Fure, 2006(42) 
Norway 
Hospital, 
Cross-sectional, 
Consecutive 
enrolment, 
Dec 2000-Jan 
2002 
I: Stroke (CT) 
E: TIA, 
moderate to 
severe aphasia, 
consciousness 
NIHSS, BI, MMSE, 
MRS 
64% 69 yrs (63%) 178 HADS-A≥8 1wk 26 (20-33) 
          
Ibrahimagic, 2005(43) Hospital, I: Ischemic  Not stated 65 yrs (50% 40 Zung≥50 2 days 30 (16-44) 
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Study name or 
author, 
 year published 
Location 
Setting/ 
Design/  
Recruitment/ 
Year of study 
Inclusion (I)/ 
exclusion (E) 
Other Measures 
administered 
% Eligible 
participating 
Mean age 
(%male)/ 
 
N Criteria Time Post 
Stroke 
Percent with 
Anxiety (95% 
CI) 
Bosnia Prospective 
longitudinal 
cohort/ 
Consecutive 
enrolment/ Year 
not state 
stroke (CT) and 
able to fill out 
self report 
questionnaire 
male) 
    40  2wk 25 (12-38) 
          
Knapp, 1998(44) 
UK 
Hospital/ Cross-
sectional/ 
Consecutive 
enrolment/ Year 
not stated 
I: Stroke within 
past month, 
sufficient 
language and 
cognition to 
undertake long 
interview, 
named carer 
also willing to 
participate, 
living 
independently 
pre-stroke 
BI, Schedule for 
Social interaction 
Not stated 69 yrs (53%) 30 HADS-A≥8 <1m 47 (29-65) 
 30  1m post 
discharge 
27 (11-43) 
 30  6m post 
discharge 
30 (14-47) 
          
Leppavuori, 2003(45) 
Finland_ENREF_
40 
Hospital/  
Cross-sectional 
cohort/ 
consecutive 
enrolment/ 
 Not stated 
I: Ischemic 
stroke (MRI) 
E: SAH, ICH, no 
clinical 
neurological 
examination, 
severe apasia, 
refusal of 
psychiatric 
examination  
BI, MMSE, SSS, 
Zung anxiety scale, 
Global Assessment 
of Functioning, 
MADRS 
57% 71 yrs (51%) 277 DSM-IV_GAD 3-4m 21 (16-26) 
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Study name or 
author, 
 year published 
Location 
Setting/ 
Design/  
Recruitment/ 
Year of study 
Inclusion (I)/ 
exclusion (E) 
Other Measures 
administered 
% Eligible 
participating 
Mean age 
(%male)/ 
 
N Criteria Time Post 
Stroke 
Percent with 
Anxiety (95% 
CI) 
          
Li, 2006(46) 
China_ENREF_6
3 
Hospital/  
Cross-sectional/ 
Random 
selection/  
2000-2002 
I: Cerebral 
infarction 
 Not stated 53 yrs (53%) 91 HADS-A>9 Not 
reported 
31 (21-40) 
          
Merriman 2007(58) 
UK 
Hospital/ 
Cross-sectional/ 
In-hospital and 
postal-mailout 
to discharged 
patients/ 
Year not stated 
 
I: ≥18 yrs & 1-12 
months post 
stroke, able to 
complete self-
report 
questionnaire 
E: Dysphasia, 
acute medical 
problems 
PDS, BI, Negative 
Affect Schedule, 
Cognitive Appraisal 
Questionnaire 
52% 74 yrs (56%) 102 HADS-A≥11 1-12m 20 (12-27) 
          
Moon, 2004(47), 
South Korea 
Hospital/ 
Cross-sectional/ 
Consecutive 
enrolment/ 
Feb- Jun 2002 
I: Stroke (MRI) BDI, BI, WHOQOL-
BREF 
Not 
reported 
Mean age 
unknown (62%) 
69 BAI≥22 2m 49 (37-61) 
          
Morris, 1990(48), 
Australia 
Hospital/ 
Longitudinal 
cohort/ 
Consecutive 
enrolment 
I:Ischemic & 
Hemorrhagic 
(WHO DFN, CT) 
E: Aphasia, 
however two 
individuals with 
minimal deficit 
included 
BI, Social class, 
MMSE, Family 
psychiatric history, 
MADRS 
Not 
reported 
71 yrs (51%) 99 DSM-III 2m 3.0 (0-6.4) 
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Study name or 
author, 
 year published 
Location 
Setting/ 
Design/  
Recruitment/ 
Year of study 
Inclusion (I)/ 
exclusion (E) 
Other Measures 
administered 
% Eligible 
participating 
Mean age 
(%male)/ 
 
N Criteria Time Post 
Stroke 
Percent with 
Anxiety (95% 
CI) 
      56  1y 5.4 (0-11) 
          
Morrison 2000 & 
2005(49, 50) 
UK 
Hospital/ 
Longitudinal 
cohort/ 
Recruitment 
over 13 months 
for patients 
admitted to 
hospital/ 
Year not stated 
 
I: residual 
disability, pass 
screening test 
for cognitive 
and 
communication 
problems 
BI, RLOC, CAPE, 
Exercise coping, 
Recovery 
confidence, 
Neurologic 
impairment 
89% 69 yrs (51%) 101 HADS-A≥11 <1m 24 (15-32) 
89% 78  2m 21 (12-29) 
93% 71  6m 23 (13-32) 
86$ 38  3y 26 (12-40) 
          
Raju, 2010(56) 
India 
Hospital/ 
Cross-sectional/ 
Patients who 
had completed 
≥1 month 
follow-up/ 
Nov 2008-Feb 
2010 
I: 1
st
 ever 
Ischemic & 
Hemorrhagic 
stroke (WHO 
dfn, CT or MRI), 
≥1 month post-
stroke 
E: history of 
psychoactive 
substance 
abuse, 
dementia, 
psychiatric co-
morbidity, 
aphasia 
FIM, WHOQoL-
BREF, NIHSS, mRS 
81% 54 yrs (70%) 162 HADS-A≥11 1.5y 11 (6.3-16) 
          
Sagen, 2010(51) 
Norway 
Hospital/ 
Cross-sectional/ 
I: Ischemic or 
hemorrhagic 
AES, BI, SSS, HADS 57% 65 yrs (59%) 104 DSM-IV 
Anxiety (ALL) 
4m  
23 (15-31) 
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Study name or 
author, 
 year published 
Location 
Setting/ 
Design/  
Recruitment/ 
Year of study 
Inclusion (I)/ 
exclusion (E) 
Other Measures 
administered 
% Eligible 
participating 
Mean age 
(%male)/ 
 
N Criteria Time Post 
Stroke 
Percent with 
Anxiety (95% 
CI) 
Consecutive 
enrolment/ 
Jan 2003-Jun 
2005 
stroke 
E: TIA, aphasia, 
psychosis, 
MMSE <20, 
terminal illness 
GAD 
PTSD 
Social phobia 
Panic with Ag. 
Panic without Ag. 
Agoraphobia 
without Panic 
OCD 
Anxiety NOS 
5.8 (1.3-10) 
2.9 (0-6.1) 
2.9 (0-6.1) 
7.7 (2.6-13) 
2.9 (0-6.1) 
3.9 (0-7.5) 
 
1.9 (0-4.6) 
1.0 (0-2.8) 
          
Sampson, 2003(52) 
UK 
Hospital/ 
Case-control/ 
Recruit from 6 
stroke units/ 
Year not stated 
I: Ischemic or 
hemorrhagic 
stroke 
E: Cognitive 
impairment, 
dysphasia, too 
physically 
unwell or 
terminal illness, 
MRSA infection 
BI, GHQ-28, IES, 
PCL-S, MMSE, 
Verbal Fluency 
Test, Digit Span 
Test, National Adult 
Reading Test 
69% Not reported 54 HADS-A≥10 Not 
reported 
26 (14-38) 
          
Schultz, 1997(53) 
USA 
Hospital/ 
Longitudinal 
cohort/ 
Consecutive 
enrolment/ 
Year unclear 
I: Stroke HAM-D, MMSE, 
STC, JHFI 
Unclear 58 yrs (57%) 142 DSM-IV_GAD Acute 
phase 
19 (13-25) 
  77  3m 22 (13-31) 
  79  6m 25 (16-35) 
  70  12m 11 (4.0-19) 
  66  2y 18 (8.9-27) 
          
Stone, 2004(54) 
UK 
Hospital/ 
Nested cross-
sectional/ 
E: Severe stroke 
with high risk of 
death, 
NEADL, carer 
distress 
71% 72 yrs median 
(60%) 
89 HADS-A≥8 1m 20 (12-29) 
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Study name or 
author, 
 year published 
Location 
Setting/ 
Design/  
Recruitment/ 
Year of study 
Inclusion (I)/ 
exclusion (E) 
Other Measures 
administered 
% Eligible 
participating 
Mean age 
(%male)/ 
 
N Criteria Time Post 
Stroke 
Percent with 
Anxiety (95% 
CI) 
Consecutive 
enrolment/ 
Year not stated 
dementia, 
aphasia, 
cognitive 
impairment, 
patients living 
alone, carer 
unable to talk 
with researcher 
          
Townend, 2007(55) 
Australia 
Hospital/ 
Longitudinal 
cohort/ 
Consecutive 
enrolment/ 
Mar-Sep 2004 
I: Ischemic or 
hemorrhagic 
stroke 
E: Dysphagia, 
MMSE<20, 
reduced level of 
consciousness 
BI, mRS, MMSE, 
Social support scale 
83% 76 yrs (49%) 125 HADS-A≥9 5 days 4.8 (1.1-8.6) 
    95%  112  1m 8.0 (3.0-13) 
    92%  105  3m 14 (7.6-21) 
          
Wanatabe, 1984(79) 
Japan_ENREF_6
5 
Hospital/ 
Cross-Sectional/ 
Random 
selection/ 
Year not stated 
E: aphasia, 
dementia 
Clinical factors Not 
reported 
57 yrs (57%) 35 TMAS 6m 51 (35-68) 
          
Zhao, 1999(57) 
China 
Hospital I: 1
st
 ever stroke 
(Chinese 
Cerebral 
Vascular 
Disease 
Symposium of 
Clinical factors Not 
reported 
63 yrs (61%) 206 Zung SAS≥50 1m 18 (13-24) 
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Study name or 
author, 
 year published 
Location 
Setting/ 
Design/  
Recruitment/ 
Year of study 
Inclusion (I)/ 
exclusion (E) 
Other Measures 
administered 
% Eligible 
participating 
Mean age 
(%male)/ 
 
N Criteria Time Post 
Stroke 
Percent with 
Anxiety (95% 
CI) 
1995 Dfn) 
E: Aphasia, - 
mental 
disorder, 
epilepsy, 
mental 
retardation, 
cerebral 
trauma  
 
          
Barker-Collo, 2007(59) 
New Zealand 
Rehabilitation, 
Cross-Sectional 
Consecutive, 
Not stated 
I: Ischemic, 
Hemorrhagic 
(CT) 
E: Aphasia, non-
native language 
speaker 
Education, Marital 
Status, BDI, FIM, 
Verbal learning, 
Memory, Impulse 
control 
81% 52 yrs (55%) 73 BAI≥26 3m 21 (11-32) 
          
Bergersen, 2010(60) 
Norway 
Rehabilitation, 
Cross-Sectional, 
Mail-out all 
patients 
1998-2001 
I: Ischemic, ICH, 
SAH 
E: Aphasia 
Marital status, 
Employment, 
Driver’s license, 
Family support, 
MRS, GHQ-30 
64% 58 yrs (64%) 162 HADS-A≥11 
 
2-5y 17 (11-22) 
          
Carod-Artal 2009(61) 
Brazil 
Rehabilitation, 
Cross-sectional, 
Consecutive, 
Jul 2007-Jun 
I: Ischemic & 
hemorrhagic 
(Clinical dx and 
radiological 
NIHSS, MRS, BI, 
MMSE, Lawton & 
Brody Scale 
(extended ADL), SIS 
77% 56 yrs (52%) 300 HADS-A≥11 20m 24 (19-29) 
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Study name or 
author, 
 year published 
Location 
Setting/ 
Design/  
Recruitment/ 
Year of study 
Inclusion (I)/ 
exclusion (E) 
Other Measures 
administered 
% Eligible 
participating 
Mean age 
(%male)/ 
 
N Criteria Time Post 
Stroke 
Percent with 
Anxiety (95% 
CI) 
2008 findings) 
E: TIA, subdural 
haematoma, 
dementia, 
aphasia, severe 
disability due to 
previous 
neurological 
disorder 
          
D’Alisa 2005(62) 
Italy 
Rehabilitation, 
Cross-sectional, 
Consecutive, 
Not stated 
E:MMSE <24, 
Aphasia 
MMSE, FIM, LHS, 
UNSS 
unclear 63 yrs (60%) 73 HADS-A≥11 5y 21 (11-30) 
          
DeWit 2008(63) 
England, Belgium, 
Switzerland, 
Germany 
Rehabilitation, 
Longitudinal 
cohort, 
Consecutive 
I: 1
st
 ever stroke 
(WHO criteria- 
CT), RMA-GF≤11 
and/or Leg 
Trunk function 
≤8  and/or Arm 
function ≤12 
E: neurological 
impairments, 
pre-stroke 
BI<50, subdural 
hematoma, 
admitted to 
rehab centre ≥6 
wks post-stroke 
BI, NIHSS, RMA-GF 95% 70 yrs (53%) 491 HADS-A≥8 2m 25 (21-29) 
95% 478  4m 23 (19-27) 
92% 467  6m 21 (18-25) 
          
Anxiety after stroke 
33 
 
 
Study name or 
author, 
 year published 
Location 
Setting/ 
Design/  
Recruitment/ 
Year of study 
Inclusion (I)/ 
exclusion (E) 
Other Measures 
administered 
% Eligible 
participating 
Mean age 
(%male)/ 
 
N Criteria Time Post 
Stroke 
Percent with 
Anxiety (95% 
CI) 
Gangstad 2009(64) 
UK 
Rehabilitation/ 
Cross-sectional/ 
All patients 
attending clinic 
approached 
meeting 
inclusion 
approached/ 
Study 
conducted over 
6 months 
E: Cognitive 
impairment 
Cognitive 
Processing of 
Trauma Scale, 
Posttraumatic 
Growth Inventory  
100% Not provided 15 HADS-A≥11 14m 6.7 (0-19) 
          
Ghika-Schmid 
1999(65) 
Switzerland 
Rehabilitation/ 
Cross-sectional/ 
Consecutive 
enrolment/ 
Year not stated 
I: 1
st
 ever stroke 
only (CT or MRI) 
 
BI, MRS, HDRS 72%  60 yrs (not 
provided) 
31 HAM-A>14 3m 29 (13-45) 
          
Giaquinto 2007(66) 
Italy 
Rehabilitation/ 
Consecutive 
enrolment/ 
I: 1
st
 ever stroke 
only (CT or MRI) 
E: TIA, SAH, 
previous stroke 
but not TIA, 
admission to 
rehab>3 weeks 
post-stroke, 
severe co-
morbidity, 
mental or 
comprehension 
impairment 
MMSE, FIM, Royal 
Free Interview, 
Cumulative Illness 
Rating Scale 
81%  70 yrs (46%) 132 HADS-A≥6 10 days 42 (33-50) 
Anxiety after stroke 
34 
 
 
Study name or 
author, 
 year published 
Location 
Setting/ 
Design/  
Recruitment/ 
Year of study 
Inclusion (I)/ 
exclusion (E) 
Other Measures 
administered 
% Eligible 
participating 
Mean age 
(%male)/ 
 
N Criteria Time Post 
Stroke 
Percent with 
Anxiety (95% 
CI) 
          
Masskulpan &  
Kuptniratsaikul 
2008(67, 68) 
Thailand 
Rehabilitation/ 
Prospective 
longitudinal 
cohort/ 
National 
registry from 
consecutive 
enrolled 
patients/ 
Mar-Dec 2006 
I: Stroke 
patients ≥18 yrs 
E: Severe 
medical 
comorbidities, 
Inability to 
communicate, 
dementia, 
schizophrenia 
or present 
psychotic 
episode 
BI, MMSE, 
WHOQOL-BREF 
Not stated 62 yrs (59%) 327 HADS-A≥11 ~24 days 5.8 (3.3-8.4) 
77%  251  2m 26 (20-31) 
         
          
Langhorne 2000(69) 
UK 
Rehabilitation/ 
Prospective 
longitudinal 
cohort/ Multi-
centre 
consecutive 
enrolment/  
7 months 
I: Stroke (WHO 
dfn) within 7 
days of onset 
BI, FIM, Clinical 
complications 
71% 76 yrs (52%) 220 Single Question 6m post 
discharge 
34 (28-40) 
82% 181 18m post 
discharge 
 
44 (37-51) 
86% 155 30m post 
discharge 
 
49 (41-57) 
          
Macniven 2005(70) 
UK 
Rehabilitation/ 
Cross-sectional/ 
2 week audit of 
all patients on 
ward/ 
Year not stated 
E: Language 
problems 
Tests for memory, 
reasoning, 
language, executive 
functioning, praxis 
& visuospatial-
perceptual 
functioning 
57% 68 yrs (47%) 17 HADS-A≥8 58.5 days 65 (42-87) 
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Study name or 
author, 
 year published 
Location 
Setting/ 
Design/  
Recruitment/ 
Year of study 
Inclusion (I)/ 
exclusion (E) 
Other Measures 
administered 
% Eligible 
participating 
Mean age 
(%male)/ 
 
N Criteria Time Post 
Stroke 
Percent with 
Anxiety (95% 
CI) 
          
Sembi 1998(71) 
UK 
Rehabilitation/ 
Cross-sectional/ 
Recruited from 
3 rehab sites/ 
Jan 1995-Apr 
1996 
I: >18 yrs with 
1
st
 ever stroke 
or TIA, able to 
complete self-
report 
questionnaire 
E: Dysphasia 
BI, EPQ, GHQ-28, 
IES, Penn 
77% 66 yrs (% male 
not reported) 
61 HADS-A≥11 18m 15 (5.9-24) 
          
Tang 2002(72) 
Hong Kong 
Rehabilitation/ 
Cross-sectional/ 
Consecutive 
enrolment/ 
Jun 1999-Aug 
2000 
 
I: 1
st
 ever stroke 
(CT) 
E: TIA, SAH, 
history of 
neurological 
impairment, 
comprehension 
and 
communication 
deficits, length 
of stay <2 wks 
BI, MMSE, mRS, 
NIHSS 
31% 71 yrs (45%) 157 DSM-III-R 25 days 0.6 (0-1.9) 
          
Vickery 2006(73) 
USA 
Rehabilitation/ 
Cross-sectional/ 
Sample of 
admitted 
patients/ 
Year not stated 
I: Stroke 
E: history of co-
morbid 
dementia, non-
stroke 
neurological 
process, acute 
delirium, severe 
psychiatric 
disturbance 
VASES, GDS, VAMS 90% 69 yrs (45%) 141 AMAS ≥65 20 days 7.8 (3.4-12) 
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Study name or 
author, 
 year published 
Location 
Setting/ 
Design/  
Recruitment/ 
Year of study 
Inclusion (I)/ 
exclusion (E) 
Other Measures 
administered 
% Eligible 
participating 
Mean age 
(%male)/ 
 
N Criteria Time Post 
Stroke 
Percent with 
Anxiety (95% 
CI) 
          
Ahlsio, 1984(74) 
Sweden 
Community 
Cross-Sectional, 
Consecutive,  
Jan-Dec 1979 
I: CI, TIA, SAH 
(CT) 
E: Severe 
disability, 
aphasia, 
dementia 
ADL, QoL, mortality 55% 71 yrs, (60%) 
 
53 Self Report 2y 26 (15-38) 
          
Bruggiman, 2006(75) 
Switzerland 
Community, 
Cross-sectional, 
consecutive, 
Not stated 
 
I: 1
st
 ever 
Ischemic or 
Hemorrhagic 
stroke 
E: NIHSS>3, 
history of 
psychiatric 
illness, 
neurologic 
comorbidity 
MRI, BI, HDRS, 
NIHSS, Memory 
assessment, IES, 
Trauma experience 
52% 51 yrs (67%) 49 HADS-A≥8 1y 24 (12-37) 
          
Gillespie, 1997(76) 
UK 
Community/ 
Cross-sectional/ 
Registry mailout 
to discharged 
patients/ Year 
not stated 
I: Stroke (WHO 
dfn) 
E: 
Communication 
difficulties, 
cognitive 
impairment, 
significant 
comorbidity, 
recent 
BI, Coping checklist 68% 69 yrs (66%) 44 HADS-A≥9 7m 25 (12-38) 
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Study name or 
author, 
 year published 
Location 
Setting/ 
Design/  
Recruitment/ 
Year of study 
Inclusion (I)/ 
exclusion (E) 
Other Measures 
administered 
% Eligible 
participating 
Mean age 
(%male)/ 
 
N Criteria Time Post 
Stroke 
Percent with 
Anxiety (95% 
CI) 
experience of 
major life event 
unrelated to 
stroke 
          
Lincoln, 1998(77) 
UK 
Community/ 
Cross-sectional/ 
74 GP practices/ 
Aug 1994-Aug 
1996 
I: Stroke (WHO 
dfn) 
BI, cognitive ability, 
Rivermead Motor 
Assessment, 
London Handicap 
Scale 
82% 76 yrs (67%) 84 HADS-A≥11 1m 26 (17-36) 
Visser-Keizer, 
2002(78) 
Netherlands 
Community/ 
Cross-sectional/ 
350 GP clinics/ 
Year not stated 
I: 1
st
 ever 
ischemic stroke 
(CT) 
E: neurologic or 
psychiatric 
history, history 
of alcohol or 
drug abuse, 
insufficient 
language and 
cognitive ability  
to allow 
assessment, 
aphasia 
BI, verbal memory, 
hemispatial neglect 
61% 67 yrs (59%) 113 HADS-A≥6 3m 14 (7.7-21) 
AES: Apathy Evaluation Scale, AMAS: Adult Manifest Anxiety Scale, AMT: Abbreviated Mental Test, BAI: Beck Anxiety Inventory, BI: Barthel 
Index CI: Cerebral Infarction, DSM: Diagnostic and Statistical Manual of Mental Disorders, EPQ: Eysenck Personality Questionnaire, FAI: 
Frenchay’s Activity Index, , FAST: Frenchay Aphasia Screening Test , GDS: Geriatric Depression Scale, GHQ: General Health Questionnaire, HADS-
A: Hospital Anxiety and Depression Scale Anxiety Subscale, HAM-A: Hamilton Anxiety Scale,  HDRS: Hamilton Depression Rating Scale, ICH: 
Intracerebral Hemorrhage, IDA-A: Irritability Depression and Anxiety Scale, Anxiety subscale, IES: Impact of Event Scale JHFI: Johns Hopkins 
Functioning Inventory, LHS: London Handicap Scale, MADRS: Montgomery-Asberg Depression Scale,  MMSE: Mini Mental State Examination, 
MRI: Magnetic Resonance Imaging, MRS: Modified Rankin Score, NHP: Nottingham Health Profile, NIHSS: National Institute of Health Stroke 
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Scale, PDS: Posttraumatic Diagnostic Scale, Penn: Penn Inventory of PTSD, PTCI: Posttraumatic Cognitions Inventory, RMA-GF: Rivermead Motor 
Assessment, SAH: Subarachnoid Hemorrhage, SF-36: Short Form-36, SIS: Stroke Impact Scale, SSS: Scandinavian Stroke Scale, STC: Social Ties 
Checklist, TIA: Transient Ischemic Attack, TMAS: Taylor Manifest Anxiety Scale, UNSS: Unified Neurological Stroke Scale, VAMS: Visual Analog 
Mood Scales, VASES: Visual Analogue Self-Esteem Scale, Zung SAS: Zung Self Rating Anxiety Scale  
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Table 2: Synopsis of rating scales used to measure anxiety symptoms 
Screening tool Details No. 
studies 
Suggested 
threshold scoring 
Cut-off scores 
reported from 
studies 
Adult Manifest 
Anxiety Scale 
(AMAS)(88) 
Self report scale with 36 to 44 
items.  Total number of anxiety 
items endorsed is summed and 
converted to an age-referenced T-
score 
1 Age dependent T-score ≥65 
Beck Anxiety 
Inventory (BAI)(89) 
Self-report 21 item scale that 
discriminates between anxiety 
and depression.  Possible score 
ranges from 0-63.  
2 0-7 minimal 
 8-15 mild 
16-25 moderate 
26-63 severe 
anxiety 
≥16, >22 
General Health 
Questionnaire-60 
(GHQ-60)(90) 
A 60 item scale used to screen for 
various aspects of psychiatric 
distress.  Includes an anxiety 
subscale.   
1 Determined by 
researcher 
≥3  out of 7 on 
anxiety subscale 
Hamilton Anxiety 
Rating Scale (HAM-
A)(91) 
Clinician administered 14 item 
scale measuring specific anxiety 
symptom clusters that are both 
psychic and somatic.  Possible 
score ranges from 0-56  
1  <17 mild 
18-24 mild to 
moderate 
≥25 severe 
anxiety 
>14 
Hospital Anxiety and 
Depression Scale, 
Anxiety subscale 
(HADS-A)(92) 
Self-report 14 item scale with 7 
items used to screen for psychic  
anxiety symptoms.  Possible score 
ranges from 0-21. 
25 0-7 minimal 
8/9 possible 
anxiety disorder 
10/11 probable 
anxiety disorder. 
≥6, ≥8, >8, ≥9, 
≥10, ≥11 
Irritability 
Depression and 
Anxiety, Anxiety 
subscale (IDA-A)(93) 
Self report scale with 5 items 
anxiety subscale.  Possible scores 
range from 0-15   
1 0-8 minimal to 
mild 
9-15 moderate to 
severe anxiety 
≥9 
Taylor Manifest 
Anxiety Scale 
(TMAS)(94) 
Clinician administered 50 item 
scale. Possible scores range from 
0-50 with higher score indicative 
of higher levels of trait anxiety.   
1 14/15 indicative 
of anxiety, 
differential sex 
based thresholds 
recommended 
>23 for 
males, >26 
females 
Zung Self Rating 
Anxiety Scale(95) 
Self report 20 item scale with 
measures of state and trait 
anxiety.  Possible scores range 
from 20-80 
2 20-44 normal 
45-59 mild to 
moderate 
60-74 severe  
75-80 extreme 
anxiety 
≥50 
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